Eli Lilly Plans to Cut Drug Exports to Canada
From Times Wire Reports
Eli Lilly and Co. will begin limiting its drug sales to Canadian pharmacies, joining other drug companies that are trying to prevent their medications from being sold to U.S. consumers from Canada.
The Indianapolis-based drug maker told 24 Canadian drug wholesalers in a letter that it will limit sales of its drugs to amounts that Lilly estimates are sufficient to supply the Canadian market only.
Because of Canadian price controls, the cheaper Canadian dollar and other factors, brand-name prescription drugs in Canada sell for 35% to 40% less than in the U.S.
